July 09, 2011

Dobber Sports

2011-07-09

 

I'm still hoping that Sean Kelly contacts me, as he won the Oakley's sunglasses. Shades can be seen by clicking here.

 

The Panthers have acquired Sergei Shirokov from Vancouver for Mike Duco. As you know, the Panthers’ roster is already filled with modest contracts and Shirokov will not steal a job. However, if someone gets hurt in camp, then he gets his shot.

 

The Panthers have also acquired Angelo Esposito from the Jets for Kenndal McArdle. The latter didn’t have a home on the roster, and Esposito is a long shot from making it to the NHL. But in the new system, perhaps in two years he can fully turn his game around.

 

Some minor deals – The Habs have signed Brian Willsie. The Red Wings have signed Chris Connor. Anaheim has signed Brian McGrattan to a two-way contract. Buffalo has signed Colin Stuart and Drew MacIntyre. Montreal has acquired Michael Blunden from Columbus for Ryan Russell (Kris Russell's twin brother, now teammate). Vancouver has signed Matt Climie and Alexander Sulzer.

 

I'll analyze the Eric Fehr deal later Saturday.

 

Further to my Florida Panthers article, I noticed some comments indicating that the length of most of the contracts that were signed were for four years, and as such they hold no trade value this year. Absolutely correct. And I'm a little embarrassed because I think I said right in the article that they signed for four years and that's because Tallon's plan is for four years. The proper way for me to present it would have been to say "Prediction: five of ANY player on the team will be dealt by the deadline." I can name some: Versteeg, Clemmensen, possibly Weiss, and the rest would depend on how great (value up) or bad (value down) the rest of the crew plays. But the plan is for four years, and the hope is that one or two of the long-term signings emerge as better players than we all thought. My guesses there would be Fleischmann and Bergenheim.

 

The one truly bad signing for the Panthers to me was Jovanovski. He is a shadow of what he once was and I would not pay him a penny over $2 million. I think out of all of them, this one is going to hurt the most.

 

Sergei Kostitsyn signed for one year at $2.5 million. While the money is decent, his signing for one year was absolutely insane. His agent should know better. His agent should better read the situation. The situation is this – Kostitsyn is one of the streakiest players in the league. He is completely useless for 20+ games of the year, and he is a Top 30 forward in the NHL for the other 60. On a team like Nashville, with a dozen guys who can post 55 points, he is easily replaceable when he goes into a funk. If he goes into a slump and the guy who replaces him makes a splash, Kostitsyn will have trouble getting that spot back. If he was signed for two years, he would have no trouble at all. I'm not saying he's a bust now. Not at all. But as a Kostitsyn owner, I was 95% comfortable with him setting a career high this season and because the deal is only for one year, my comfort level just went down to 75%.

 

When I ramble and muse about the subtleties of fantasy hockey, that is all that they are – subtleties. So if I get you all excited or down on a player from what I say, take it with a grain of salt. Like in the above example, if I left that blurb without that final sentence, and on some days I may have, you would possibly be scared to own SK. But when I say something hurts or helps, it's generally just a slight bump in the odds. And fantasy hockey is all about those slight bumps. That edge. My fourth year magic analysis is another example of this. My sophomore slump analysis is yet another. If you can up your odds of getting a good player by 1%, or avoid a bust by 1%, then that's huge.

 

📢 advertisement:

The Rangers have re-signed Artem Anisimov to a two-year extension.

 

The Leafs have signed Matt Lashoff and Philippe Dupuis to two-way deals.

 

Craig Leipold on Guillaume Latendresse: "Well, first of all, he came to camp out of shape. Let's just call it like it is. He will not come into camp this year out of shape. That's just the way it's going to be. And he has a trainer that is working with him, I've been told, everyday. And I ask this question a lot because Latendresse is a very important part of our team. And the statement that he will make when he walks in the locker room when camp opens up in August, the statement that he makes when he walks in that room and he's in shape is going to be a powerful statement of who he is, how hard he wants to win, how hard he wants to play. I know for a fact that our people are there, our people being from St. Paul are going to visit him almost every other week to make sure he is staying in his routine and staying in shape, eating right, everything else like that. So I feel good about Gui Latendresse next year."

 

This is a pretty nice looking LA Kings roster, no?

 

I remember sitting at the bar with a buddy and watching the Toronto game, and I nudged him and told him to turn to the other TV, because there was a fight in the Ottawa/Philly game. When that was over, we turned our heads back to the Leafs. A minute later, I nudged him again – another fight. Fight ended, back to the Leafs. Seconds later, another fight. At this point we just turned our chairs right around and started watching the Sens/Flyers. That's what I remember about this game. Here are the two-part clips…

 

 

 

Leave A Comment

UPCOMING GAMES

Apr 26 - 19:04 WSH vs NYR
Apr 26 - 19:04 NSH vs VAN
Apr 26 - 22:04 COL vs WPG
Apr 26 - 22:04 L.A vs EDM

Starting Goalies

Top Skater Views

  Players Team
ALEX VLASIC CHI
STEVEN STAMKOS T.B
JAKE GUENTZEL CAR
QUINTON BYFIELD L.A
SEBASTIAN AHO CAR

Top Goalie Profile Views

  Players Team
STUART SKINNER EDM
THATCHER DEMKO VAN
FREDERIK ANDERSEN CAR
ILYA SOROKIN NYI
IVAN PROSVETOV COL

LINE COMBOS

  Frequency VGK Players
23.8 MARK STONE CHANDLER STEPHENSON TOMAS HERTL
19.4 JONATHAN MARCHESSAULT JACK EICHEL IVAN BARBASHEV
14.8 NICOLAS ROY KEEGAN KOLESAR WILLIAM CARRIER

DobberHockey Podcasts

FIND US ON FACEBOOK

📢 advertisement: